Trial intelligence / Profile preview

TRAVATAN Z vs XALATAN Ocular Surface Effects

NCT00798759Phase 4Completed

Sponsor
Alcon Inc.
Start
Dec 2008
Primary completion
May 2009
Modality
Prodrugs/Conditional Activator Small Molecules
01

Overview

A Phase 4 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Dec 2008; status: completed.

02

Drugs

travoprost
03

Conditions

open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on NCT00798759.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00798759.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call